Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Should you get a stent before kidney stone surgery with a tiny scope?

Official title: Does Pre-stenting Still Have a Role in Retrograde Intrarenal Surgery in the Era of Miniaturized Flexible Ureteroscopes? Surgical Outcomes From a Prospective Randomized Controlled Trial

Run by Al-Azhar University · NCT07773090 · Data updated 2026-11-12

In adults with 10–20 mm unilateral kidney stones, this study tests whether doing a retrograde intrarenal surgery (RIRS) after a planned preoperative ureteral stent is better than doing RIRS directly without a stent.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment270 (estimated)
SponsorAl-Azhar University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedAugust 19, 2026
Main results expectedAugust 14, 2028
Study endsNovember 1, 2028
Registry record updatedAugust 21, 2026
Trial IDNCT07773090 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18–70 with unilateral renal calculi 10–20 mm planned for RIRS and no contraindications to elective endoscopic stone treatment.

Probably not a fit

Patients who have contraindications to stenting or those unlikely to benefit from staged procedures may see no advantage from pre-stenting.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares two approaches to RIRS for unilateral renal stones 10–20 mm using miniaturized flexible ureteroscopes. One group receives a preoperative double-J stent for 7–14 days before RIRS, while the other group undergoes direct RIRS without planned pre-stenting, with rescue stenting allowed if access is not initially possible. The primary outcome is the stone-free rate on CT at 4 weeks after the final RIRS; secondary outcomes include access success, need for dilation, procedure time, complications, hospital stay, and postoperative symptoms. All procedures use a standardized miniaturized digital flexible ureteroscope and holmium:YAG laser lithotripsy. The trial will help determine if routine pre-stenting improves outcomes or if direct RIRS with modern tools is sufficient.

Why it matters

Potential benefit: If successful, the trial could simplify care by reducing unnecessary preoperative stenting and potentially shorten recovery.

How similar studies have gone: Similar approaches have shown mixed results; some studies suggest benefits of pre-stenting for access, while others indicate no clear advantage with modern miniaturized scopes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants must meet all of the following criteria:

  * Adults aged 18-70 years.
  * Unilateral renal calculi.
  * Maximum total renal stone burden of 10-20 mm.
  * Planned treatment with RIRS.
  * Suitable candidate for elective endoscopic stone treatment.
  * Negative or appropriately treated preoperative urine culture.
  * Ability to provide written informed consent.
  * Ability and willingness to comply with postoperative follow-up, including non-contrast CT at 4 weeks after the final RIRS procedure.

Exclusion Criteria:

* Participants will be excluded for any of the following:

  * Bilateral renal calculi requiring simultaneous surgical treatment.
  * Active urinary tract infection, sepsis, or infected obstruction requiring urgent drainage.
  * Solitary kidney when randomization is considered clinically unsafe.
  * Known ureteral stricture or congenital ureteral abnormality likely to interfere with ureteroscopic access.
  * Previous failed ipsilateral ureteroscopic access requiring clinically indicated pre-stenting.
  * Existing ipsilateral ureteral stent or nephrostomy.
  * Previous ureteral reconstruction or urinary diversion.
  * Total renal stone burden greater than 20 mm.
  * Staghorn calculi.
  * Uncorrected coagulopathy.
  * Pregnancy.
  * Severe uncorrected cardiopulmonary disease precluding anesthesia.
  * Inability or unwillingness to provide informed consent.
  * Inability or unwillingness to comply with follow-up.
  * Any other condition judged by the treating surgeon to make randomization or RIRS clinically inappropriate or unsafe.

Where it's running

  • Department of Urology, Al-Hussein and Sayed Galal University Hospitals, Al-Azhar University
    Cairo, Egypt
    Recruiting

Study contacts

  • Principal investigator: Abul-fotouh Ahmed, MD — Department of Urology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
  • Study coordinator: Abul-fotouh Ahmed, MD
  • Email: abulfotouhahmed@yahoo.com
  • Phone: 00201001066756

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.